Sunday, August, 25, 2019 02:48:01

Contrast Media Injectors Market size is projected to experience significant growth from 2019 to 2025. The prevalence as well as incidence of chronic diseases is expected to rise in the forthcoming years across the globe. Additionally, the pervasiveness of multimorbidity is also increasing along with chronic diseases. Cases of chronic diseases such as cancer and cardiovascular diseases are increasing and will continue to increase over the period of forecast, that will require early and accurate diagnosis through various imaging systems like Computed tomography scanners and MRI equipments that require contrast media injectors. According to the World Health Organization, the geriatric population is expected to double by 2025, globally. Factors like aging population and lifestyles contributing to the incidence of the chronic diseases will result in contrast media injectors industry growth.

Rising public awareness of early diagnosis of disease will further assist the contrast media injectors market growth. The patient population are preferring access to rapid and accurate diagnosis of their diseases. The detailed information of the patient disease diagnosis helps the population to increasingly favor the imaging diagnostic systems. Hence, a lucrative growth in the CT scanners and MRI equipments will in turn boost the growth of contrast media injectors market.

Request In-depth table of contents @

Technological advancements in contrast media injectors have propelled the market growth for these injectors. Recent developments include cost reductions, that is achieved through minimum contrast waste generation and automated patient data collection. Personalized patient dosage is given by accessing patient EMRs (electronic medical record) and PACS (picture archiving and communication system). Latest advances also include syringeless power injectors for reduction of contrast media wastage. For instance, in November 2016, Bracco Diagnostics announced the availability of CT Exprès 3D Contrast Media Delivery System that is a multi-patient, multi-dose syringe-free injector for computed tomography for optimizing patient care in the CT department.

However, product recalls and side effects such as itching, hypersensitivity reactions, contrast-induced nephropathy and thyroid dysfunction due to contrast media can restrain contrast media injectors market growth.

The injector systems segment is the most lucrative segment owing to its large base usage for cardiovascular surgery, neurosurgery, and spinal operations. Furthermore, availability of technological advanced products in this area further fuels the injector systems segment growth.

Make Inquiry about this report @

The single head injector segment is the largest contributing segment of the contrast media injectors market. This can be attributed to its wide application in diagnostic imaging and angiography. Easy availability of novel products will further augment the single head injector segment growth.

The radiology segment will grow at a momentous rate that can be credible to the incidence of chronic diseases such as cancer, cardiovascular conditions and gastrointestinal diseases. A great impetus to the imaging systems will drive the radiology segment revenue.

Hospitals segment will witness a significant growth over the forecast period owing to the rising hospital admissions for detection of a wide range of chronic diseases. Presence of a broad range of facilities for medical imaging systems in hospitals will further fetch a large revenue forthe hospitals segment.

U.S. will dominate the contrast media injectors market due to an excellent healthcare infrastructure as well as availability of technologically advanced products. Rising aging population resulting in high incidence of chronic diseases will further enhance the contrast media injectors market growth.

India will foresee a lucrative growth in Asia-Pacific region owing to the improvements in healthcare infrastructure and a rising patient pool with chronic diseases.

The key industry competitors of the contrast media injectors market include Apollo Rt Co., Bayer HealthCare, Bracco Group, GE Healthcare, Guerbet Group     , Medtron, Nemoto Kyorindo Co., Sino Medical-Device Technology Co., Ulrich GmbH & Co. and Vivid Imaging. The companies adopt new product launches for expanding its contrast media injectors market. For instance, in March 2017, GE Healthcare launched MRI contrast media injector system, Clariscan, for a quick diagnosis of abnormalities.

Company Profiles:

  • Apollo Rt Co.
  • Bracco Group
  • Bayer HealthCare
  • Guerbet Group
  • Medtron
  • Ulrich GmbH & Co.
  • GE Healthcare
  • Nemoto Kyorindo Co.
  • Sino Medical-Device Technology Co.
  • Vivid Imaging